PTAB statistics

PTAB Trial Statistics as of February 19, 2015

As of February 19, 2015, USPTO records show 2,831 AIA trial petitions filed since September 16, 2012 (2,519 IPR, 302 CBM, 4 PGR, 6 derivation). The Board had instituted trial on 1,259 petitions and denied 662 (65.5% instituted) and had issued 296 final written decisions. In fiscal year 2015 to that date, 750 petitions were filed.

Key Facts

As of
February 19, 2015
Fiscal year
FY2015
Petitions filed (cumulative)
2,831
Institution rate (cumulative)
65.5%
Petitions filed (FY2015 to date)
750
Data retrieved
October 31, 2026
On this page
  1. Cumulative Figures as of February 19, 2015
  2. Fiscal Year 2015 to Date
  3. Change Since February 5, 2015
  4. Trial Types Covered
  5. How These Figures Were Compiled
  6. Related Statistics

This page gives Patent Trial and Appeal Board trial figures as of February 19, 2015, which falls in fiscal year 2015 (October 1, 2014 to September 30, 2015). The cumulative figures run from September 16, 2012, when AIA trials began. The full year is covered on the FY2015 statistics page.

Cumulative Figures as of February 19, 2015

Events from September 16, 2012 to February 19, 2015, by trial type:

MeasureIPRPGRCBMDERTotal
Petitions filed2,519430262,831
Institution decisions: instituted1,126013301,259
Institution decisions: denied5852723662
Institution rate (by petition)65.8%0.0%64.9%0.0%65.5%
Final written decisions2630330296
Terminations without a final written decisionCount
Settlements262
Adverse judgment0
Dismissed0
Other terminations15

Fiscal Year 2015 to Date

Events from October 1, 2014 to February 19, 2015:

MeasureIPRPGRCBMDERTotal
Petitions filed6782691750
Institution decisions: instituted3870260413
Institution decisions: denied2322160250
Institution rate (by petition)62.5%0.0%61.9%—62.3%
Final written decisions1130160129
Terminations without a final written decisionCount
Settlements118
Adverse judgment0
Dismissed0
Other terminations7

Change Since February 5, 2015

Between the previous dated page (February 5, 2015) and February 19, 2015, 74 petitions were filed, 36 trials were instituted, 59 petitions were denied institution and 18 final written decisions issued. The cumulative institution rate moved from 67.0% to 65.5%.

Trial Types Covered

2,519 of the 2,831 petitions (89.0%) were for inter partes review, which challenges patent claims on prior-art grounds under 35 U.S.C. chapter 31. The remainder were for covered business method review (302), post-grant review under chapter 32 (4) and derivation proceedings (6). Institution standards differ by proceeding; see the threshold standards.

How These Figures Were Compiled

The figures are counted from USPTO Open Data Portal records retrieved on October 31, 2026, keeping only events dated on or before February 19, 2015: a petition by its filing date, an institution decision by its decision date, and a final written decision or termination by its date. They are a reconstruction from the current records, not the USPTO’s report of that date, and may differ from statistics the USPTO published at the time. Final written decision outcomes are not reported because the records state them for too few decisions. The methodology gives the counting rules in full.

Frequently Asked Questions

How many AIA trial petitions had been filed as of February 19, 2015?

USPTO records show 2,831 petitions filed from September 16, 2012 to February 19, 2015: 2,519 IPR, 302 CBM, 4 PGR and 6 derivation.

What was the PTAB institution rate as of February 19, 2015?

Cumulatively, 65.5% by petition: 1,259 instituted and 662 denied. In FY2015 to that date the rate was 62.3%.

Primary Sources

  1. USPTO Open Data Portal (PTAB trial proceedings and decisions data)
  2. USPTO Patent Trial and Appeal Board statistics
  3. 35 U.S.C. chapter 31 (inter partes review)
  4. 35 U.S.C. chapter 32 (post-grant review)
  5. 37 C.F.R. Part 42 (trial practice before the PTAB)

Educational information; not legal advice. Statutes, rules and USPTO practice change. Confirm against the primary sources and consult a registered patent practitioner before acting. Disclaimer.